<DOC>
	<DOC>NCT01548326</DOC>
	<brief_summary>The purpose of this study is to determine whether short-term Atorvastatin can increase the immunity response to hepatitis B vaccination in vaccine Nonresponders.</brief_summary>
	<brief_title>Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine</brief_title>
	<detailed_description>20 person of vaccinated individuals who have HBsAb&lt;10 after 3 dose hepatitis B vaccination who called Nonresponders will be randomly allocated in 2 groups. one group receive short-term Atorvastatin and other group receive placebo.both group will be vaccinated with hepatitis B vaccine and then immunity response will be measured.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Previous 3 dose hepatitis B vaccination Negative HBc Ab Negative HBs Ag HBs Ab less than 10 in ELIZA positive serologic evidence of Hepatitis B infection Chronic use of Atorvastatin Immunosuppressive Disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Vaccination Failure</keyword>
	<keyword>Nonresponder</keyword>
	<keyword>Hepatitis B virus</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Immunization against viral Hepatitis</keyword>
</DOC>